Accustem Sciences (ACUT) Other Accumulated Expenses (2022 - 2026)

Accustem Sciences (ACUT) has reported Other Accumulated Expenses for 5 consecutive years, with $4.7 million the latest figure, recorded in Q1 2026.

• In Q1 2026, Other Accumulated Expenses rose 72.78% year-over-year to $4.7 million; the TTM figure through Mar 2026 stood at $4.7 million (up 72.78% YoY), while the FY2025 annual figure was $4.2 million, up 24087.17% from the prior year.
• Other Accumulated Expenses grew to $4.7 million in Q1 2026 per ACUT's latest filing, from $4.2 million in the prior quarter.
• Across five years, Other Accumulated Expenses topped out at $4.7 million in Q1 2026 and bottomed at $3180.0 in Q3 2025.
• Historically, Other Accumulated Expenses has averaged $1.2 million across 5 years, with a median of $59433.5 in 2023.
• Annual changes were most pronounced in 2024 — Other Accumulated Expenses sank 98.8% — and 2025, when it surged 36846.39%.
• Accustem Sciences' Other Accumulated Expenses stood at $24852.0 in 2022, then surged by 5754.6% to $1.5 million in 2023, then tumbled by 98.8% to $17459.0 in 2024, then jumped by 24087.17% to $4.2 million in 2025, then rose by 10.88% to $4.7 million in 2026.
• Business Quant data shows ACUT's Other Accumulated Expenses at $4.7 million in Q1 2026, $4.2 million in Q4 2025, and $3180.0 in Q3 2025.